Showing results (611-620 of 940) with videos related to

Sort By:
Pageof 94
Epidemiology and Infection|October 31, 2002
Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000S Dutta, K Rajendran, S Roy, et al.
Veterinary World|December 28, 2020
Readily usable strategies to control mastitis for production augmentation in dairy cattle: A reviewChampak Bhakat, A Mohammad, D K Mandal, et al.
Biochemistry|January 26, 2007
Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growthAnita Chaudhari, Magdy Mahfouz, Arsenio M Fialho, et al.
Resuscitation|June 13, 2025
Impact of Language Barrier During Emergency Call on Out of Hospital Cardiac Arrest Treatment and OutcomesIshani Joshi, Kosuke Kume, Christopher Drucker, et al.
JACC. Heart Failure|June 23, 2014
Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapyNeal A Chatterjee, Gaurav A Upadhyay, Gaurav Singal, et al.
Tropical Animal Health and Production|March 30, 2022
Effect of supplementation of phytogenic feed additives on intake, in vitro fermentation, growth performance and carcass traits in weaned Barbari kids reared under intensive feedingIndu Chaturvedi, T K Dutta, P K Singh, et al.
Cancer Research|January 17, 2009
Noncationic peptides obtained from azurin preferentially enter cancer cellsBrad N Taylor, Rajeshwari R Mehta, Tohru Yamada, et al.
Diabetes|May 20, 1999
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cellsZ Y Jiang, Q L Zhou, A Chatterjee, et al.
Heart Rhythm|December 28, 2018
Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT StudyQuynh A Truong, Jackie Szymonifka, James L Januzzi, et al.
European Heart Journal|January 10, 2017
Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillatorNeal A Chatterjee, Rasmus Borgquist, Yuchiao Chang, et al.
Pageof 94